Infectious disease experts warn that new drugs are urgently needed to treat six drug-resistant bacteria that cause most hospital infections and increasingly escape the effects of antibiotics.
Get the full story...
'Superbug' bacteria which have developed resistance to the most common and effective antibiotics have been a big problem in hospitals for many years.
Get the full story...
California’s authorities have issued an order for hospitals to report incidents of staph infection that lead to lethal outcome or intensive medical aid for patients.
Get the full story...
Governor of Virginia Timothy M. Kaine today approved an emergency regulation by the State Health Commissioner that requires laboratories to report Methicillin-resistant Staphylococcus aureus (MRSA) infection to the Virginia Department of Health (VDH). The regulation is effective today, and will assist public health authorities in the effort to compile data on the prevalence of MRSA for surveillance and investigation.
Get the full story...
Methicillin-resistant staphylococcus aureus (MRSA), a drug-resistant strain of bacteria, also called superbug, killed nearly 19,000 Americans in 2005, according to a new study in the Journal of the American Medical Association.
Get the full story...
As Virginia teen dies of the a bacterial infection called MRSA or methicillin-resistant staphylococcus aureus, the 'Superbug' we are faced with two important health facts:
Get the full story...
Biomedical researchers at Boston University’s College of Engineering may have discovered the path toward developing better drugs capable of defeating so-called “superbugs,” bacteria that have developed resistance to common antibiotics. The researchers have discovered a previously unknown chain of events occurring in bacteria that opens to door to new avenues of research.
Get the full story...
A novel antibacterial medicine that kills the superbug MRSA is being developed under a new scheme launched by the Wellcome Trust. The Seeding Drug Discovery initiative is aimed at catalysing the development of new drugs in areas of unmet need.
Read the full story